在26名儿童死于有毒糖浆后,700多名印度咳嗽糖浆制造者正在接受检查,这促使人们回想起、逮捕和新的安全规则。 Over 700 Indian cough syrup makers are under scrutiny after 26 children died from toxic syrup, prompting recalls, arrests, and new safety rules.

印度有700多家止咳糖浆制造商正受到政府审查，此前中央邦有26名儿童因受污染的Coldrif糖浆导致肾衰竭死亡。 Over 700 cough syrup manufacturers in India are under government scrutiny after 26 children in Madhya Pradesh died from kidney failure linked to contaminated Coldrif syrup. 测试发现二乙基甘醇含量超过Sresan制药公司0.1%的限量样本, 导致公司吊销执照、刑事指控和多个州的产品禁令。 Testing found diethylene glycol levels up to 46.28%—far above the 0.1% limit—in samples from Sresan Pharmaceuticals, leading to the company’s license revocation, criminal charges, and product bans in multiple states. 印度药典委员会更新了测试标准,要求对口服液体中的有毒物质进行检查,而监管者则加紧审计、市场监督和回顾。 The Indian Pharmacopoeia Commission updated testing standards to require checks for toxic substances in oral liquids, while regulators intensified audits, market surveillance, and recalls. 政府发布咨询意见,敦促合理使用儿科糖浆,并更加严格地执法,以防止今后发生此类事件。 The government issued advisories urging rational use of pediatric syrups and stricter enforcement to prevent future incidents.